N
Nucorionpharma
The startup develops a liver-targeting technology that effectively bypasses resistance mechanisms in cancer cells to treat liver diseases. This approach provides healthcare professionals with a reliable method to combat both cancer and viral infections affecting the liver.
Traction –/10
San Diego, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a liver-targeting technology that effectively bypasses resistance mechanisms in cancer cells to treat liver diseases. This approach provides healthcare professionals with a reliable method to combat both cancer and viral infections affecting the liver.